FDA Approved: TRI-SPRINTEC — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved Teva Pharmaceuticals' supplemental application for Tri-SprinTEC, a generic combined oral contraceptive containing norgestimate and ethinyl estr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception

Drugs mentioned

• TRI-SPRINTEC (NORGESTIMATE AND ETHINYL ESTRADIOL)

Snippet

SUPPL AP for TRI-SPRINTEC (NORGESTIMATE AND ETHINYL ESTRADIOL)